PD-L1, typically expressed on the surface of tumor cells, is bound to PD-1 on tumor-infiltrating lymphocytes, thereby inhibiting T-cell functions and consecutively inducing tumor immune escape [4,5,6,7]. This evidence concerns the gene PDCD1 and neoplasm.